A combination of two already-FDA approved drugs may offer a new treatment option against diseases in which blood vessel growth is abnormal, says a new study by researchers at Weill Cornell Medical College. Abnormal blood vessel growth is seen in conditions such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis. Their study, published in the Sept. 11 issue of the journal iDevelopmental Cell/i, is the first to show that a protein, ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment